🇮🇳 India Warehouse URSODEOXYCHOLIC ACID — 500mg per tablet, 100-count pack. Primary biliary cholangitis (PBC), cholestasis of pregnancy, gallstone dissolution (radiolucent stones), and non-alcoholic fatty liver disease (NAFLD).
Key warning: Only effective for radiolucent (cholesterol) gallstones — not radiopaque. Monitor liver function regularly. Antacids containing aluminum/magnesium reduce absorption. Avoid in complete biliary obstruction.
🌏 China Warehouse Vilon 20mg | 10-Vial Kit | Khavinson dipeptide bioregulator for thymic and immune function — T-cell modulation, cytokine regulation, and immune system geroprotection studies. ≥99% HPLC, Janoshik COA. Research use only.
🌏 China Warehouse Vilon 20mg | 10-Vial Kit | Khavinson dipeptide bioregulator for thymic and immune function — T-cell modulation, cytokine regulation, and immune system geroprotection studies. ≥99% HPLC, Janoshik COA. Research use only.
🇮🇳 India Warehouse ACARBOSE — 0.2mg per tablet, 100-count pack. Alpha-glucosidase inhibitor for type 2 diabetes and longevity/anti-aging protocols. Reduces postprandial blood glucose spikes. Studies show potential lifespan extension in animal models.
Key warning: GI inflammation or intestinal obstruction contraindicated. Hypoglycemia only when combined with insulin or sulfonylureas — treat with glucose (NOT sucrose/table sugar — won't absorb). Monitor liver enzymes.
🇮🇳 India Warehouse ACARBOSE — 0.3mg per tablet, 100-count pack. Alpha-glucosidase inhibitor for type 2 diabetes and longevity/anti-aging protocols. Reduces postprandial blood glucose spikes. Studies show potential lifespan extension in animal models.
Key warning: GI inflammation or intestinal obstruction contraindicated. Hypoglycemia only when combined with insulin or sulfonylureas — treat with glucose (NOT sucrose/table sugar — won't absorb). Monitor liver enzymes.
🇮🇳 India Warehouse COLCHICINE — 0.5mg per tablet, 100-count pack. Gout (acute flares and prevention), familial Mediterranean fever, pericarditis, and cardiovascular event reduction in coronary artery disease (proven in COLCOT and LoDoCo2 trials).
Key warning: Low therapeutic index — potentially life-threatening toxicity if overdosed (no antidote). Significant interactions with CYP3A4/P-gp inhibitors (macrolides, statins, cyclosporine — dose reduction needed). Renal and hepatic dose adjustment.